Innovation at Core
Science & Technology
We continuously invest in R&D and expand our scientific research team to drive innovation. Our R&D pipeline focuses on developing cutting-edge biotechnological solutions, including BIO-APIs, recombinant bioreagents and therapeutic peptides.
We prioritize projects with significant potential to enhance product quality and efficiency, ensuring they meet stringent regulatory standards and market demands.
Research Focus
In the competitive manufacturing landscape, we prioritize research by investing in cutting-edge technologies to enhance bio-products.
- Directed evolution to create novel proteins with desired properties
- Protein engineering to design and modify proteins for improved functionality
- CRISPR-Cas-based gene editing for precise genetic modifications
- Synthetic biology to design and construct novel biological systems and expression platforms
Together, these areas reflect our commitment to advancing Biomanufacturing sector.
Our R&D Strategy
Our R&D strategy is driven by a world-class in-house development team dedicated to ongoing innovation and value creation. We focus on continuous innovation across our portfolios to create value-generating products. We prioritize sustainable methods in developing new products, aligning with global environmental goals.
Focus Areas:
Cutting-edge Technologies
We are dedicated to building and investing in cutting-edge technologies to accelerate our scientific endeavors, helping us expand and push the boundaries of science.
Sustainable Methods
Developing new products through sustainable, eco-friendly methods.
Advanced Techniques
Utilizing advanced molecular biology and modern bioprocessing techniques.
Bioinformatics
Incorporating bioinformatics and data analytics to optimize research outcomes.
Recombinant Innovation
Innovating in recombinant protein and enzyme production workflows.
Comprehensive Capabilities
Strain Development
- Gene-to-product development
- Strong expertise in vector design and Molecular cloning
- High throughput clone selection
- Wide range of host systems
Process Development
- Upstream process development for high cell density fermentation
- Media and feed development
- Product recovery and chromatographic purification processes
- Liquid and lyophilization process development
- Process development by Design of Experiments (DOE)
Analytical Development
- Wide range of protein and enzyme assays
- Bio-physical and biological characterization assays
- HPLC, Mass spectrometry (MS), NMR and CD Spectral analysis
- Cell based immunoassays
- Method development and validations as per ICH guidelines
Manufacturing Capabilities
- Versatile manufacturing capable of producing complex biotech products
- Upstream fermentation & Wide range of purification technologies
- Large-scale yielding upto multi kL fermentation capacity
- Products in liquid and lyophilised forms
- Utilizes single-use manufacturing technologies for safety
- cGMP-certified facility adhering to ISO 9001:2015 and GMP standards
Development Pipeline
Bio-APIs
- Botulinum Toxin
- Collagenase
Recombinant Proteins & Enzymes
- Proteinase K
- Recombinant Insulin
- Transferrin
- DNA Polymerase
Synthetic Peptides
- ACTH (Desmopressin)
- Buserelin (Degarlix)
- Degarelix
- Leuprolide
- Octreotide
Globally Recognized
Quality Systems
Quality is engineered into every stage of our operations. We maintain a robust, globally compliant quality management system designed to meet and exceed rigorous international regulatory expectations for biomanufacturing.
Explore Collaboration Opportunities
Contact us to learn more about our development pipeline and explore opportunities for collaboration and partnership in bringing several bioproducts to market.
Partner With Us